SCHEMBL6844072

SCHEMBL6844072

CCNCCCCN1CN(c2ccccc2)C(c2ccccc2)=C1c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.35
ATM Q13315 1/20 0.35
ADRB2 P07550 1/20 0.33
PRMT6 Q96LA8 1/20 0.33
OPRM1 P35372 3/20 0.32
OPRD1 P41143 3/20 0.32
OPRK1 P41145 3/20 0.32
OPRL1 P41146 3/20 0.32
HTT P42858 1/20 0.32
SIGMAR1 Q99720 1/20 0.31
CACNA1G O43497 1/20 0.31
DRD2 P14416 5/20 0.31
HTR1A P08908 3/20 0.31
HTR2A P28223 3/20 0.31
HTR7 P34969 3/20 0.31
HTR6 P50406 3/20 0.31
SOAT2 O75908 2/20 0.31
SOAT1 P35610 2/20 0.31
DRD4 P21917 2/20 0.31
DRD3 P35462 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6844083 0.99 MAPT (0.34) MAPTATMADRB2PRMT6OPRM1
SCHEMBL6839506 0.96 MAPT (0.35) MAPTATMADRB2PRMT6OPRM1
SCHEMBL6844344 0.86 L3MBTL1 (0.38) MAPTATMOPRK1HTTSIGMAR1
SCHEMBL6844356 0.85 SIGMAR1 (0.40) MAPTATMPRMT6OPRK1HTT
SCHEMBL6844315 0.85 ADRB2 (0.35) ADRB2PRMT6HTTSIGMAR1DRD2
SCHEMBL6844080 0.85 ADRB2 (0.35) ADRB2PRMT6HTTSIGMAR1DRD2
SCHEMBL6847081 0.84 HTT (0.36) ADRB2PRMT6HTTSIGMAR1DRD2
SCHEMBL6844322 0.84 HTT (0.36) ADRB2PRMT6HTTSIGMAR1DRD2
SCHEMBL6839538 0.82 SLC6A2 (0.40) MAPTATMPRMT6OPRK1HTT
SCHEMBL6839497 0.81 ADRB2 (0.36) ATMADRB2PRMT6HTTSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040162328-A1 Compounds of the family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents L'OREAL (FR) 2004-08-19 US claimed
US-20040162328-A1 Compounds of the family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents L'OREAL (FR) 2004-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162328-A1 Compounds of the family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents TRPV1, TRPA1, TRPV3 MAPT 4408/4885ATM 4325/4885ADRB2 536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.